Ovarian Carcinoma-associated Antigen Antibody (5F281): sc-71758

Ovarian Carcinoma-associated Antigen Antibody (5F281) is a mouse monoclonal IgG2b antibody that detects Ovarian Carcinoma-associated Antigen of human origin by immunofluorescence (IF) and flow cytometry (FCM). Anti-Ovarian Carcinoma-associated Antigen antibody (5F281) is available as a non-conjugated format. Ovarian Carcinoma-associated Antigen plays a crucial role in ovarian cancer progression, showing overexpression in malignant cells, making Ovarian Carcinoma-associated Antigen a valuable biomarker for diagnosis and therapeutic targeting. Ovarian Carcinoma-associated Antigen primarily localizes on ovarian cancer cell surfaces, facilitating cell adhesion and interaction with tumor microenvironment, essential for tumor growth and metastasis. Ovarian Carcinoma-associated Antigen presence in peritoneal fluid can lead to cancer cell dissemination, contributing to ovarian cancer′s aggressive nature. Anti-Ovarian Carcinoma-associated Antigen antibody (5F281) enables researchers and healthcare professionals to study ovarian cancer progression mechanisms and develop effective diagnostic and treatment strategies. Ovarian Carcinoma-associated Antigen (5F281) monoclonal antibody′s specificity for targets like human folate receptor-α and CF511 highlights potential applications in diagnosis and monitoring of ovarian cancer, supporting improved patient outcomes.